Entrar/Registro  
INICIO ENGLISH
 
Dermatología Revista Mexicana
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Dermatología Revista Mexicana >Año 2016, No. 6


Welsh-Lozano O, Salinas-Carmona MC, Ocampo-Candiani J, Vera-Cabrera L
La Micología en la Facultad de Medicina de la Universidad Autónoma de Nuevo León
Dermatología Rev Mex 2016; 60 (6)

Idioma: Español
Referencias bibliográficas: 44
Paginas: 545-550
Archivo PDF: 310.87 Kb.


Texto completo




RESUMEN

El estudio de la micología en la Facultad de Medicina de la Universidad Autónoma de Nuevo León tiene sus inicios en los decenios de 1950 y 1970 por catedráticos egresados de la Universidad de Michigan. El primer laboratorio de Micología se inauguró en 1974. En él se ha sistematizado el estudio de hongos y actinomicetos, así como hongos patógenos y contaminantes, con lo que se ha organizado una micoteca. Se iniciaron estudios con los primeros antifúngicos de tipo azólico en Candida y posteriormente, en 1998, se fundó el Laboratorio Interdisciplinario de Investigación Dermatológica, en el que se realizaron todos los estudios de doctorado en medicina y ciencias, así como de maestrías que se han publicado en revistas arbitradas de alto impacto. En la actualidad la investigación en actinomicetos, micobacterias y hongos se realiza con la ayuda de técnicas de biología molecular y genómica.


Palabras clave: micología, laboratorio de micología, actinomicetomas, micobacterias.


REFERENCIAS

  1. Lira RM, Flores AY, Carmona MC, Stern AO. Experimental granulomatous pulmonary nocardiosis in BALB/C Mice. PLoS One 2016;11:e0157475.

  2. Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH. Mycetoma medical therapy. PLoS Negl Trop Dis 2014;8:e3218.

  3. Meester I, Rosas-Taraco AG, Salinas-Carmona MC. Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells in vitro and in vivo. PLoS One 2014;9:6.

  4. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Current treatment for Nocardia infections. Expert Opin Pharmacother 2013;14:2387-2398.

  5. Meester I, Rosas-Taraco AG, Salinas-Carmona MC. Retnla down-regulation and IL-13-rich environment correlate with inflammation severity in experimental actinomycetoma by Nocardia brasiliensis. Pathog Dis 2013;67:214-220.

  6. Trevino-Villarreal JH, Vera-Cabrera L, Valero-Guillén PL, Salinas-Carmona MC. Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice. Infec Immun 2012;80:3587-3601.

  7. Salinas-Carmona MC, Rosas-Taraco AG, Welsh O. Systemic increased immune response to Nocardia brasiliensis coexists with local immunosuppressive microenvironment. Antonie Van Leeuwenhoek 2012;102:473-480.

  8. Vera-Cabrera L, Salinas-Carmona MC, Waksman N, Messeguer-Pérez J, et al. Host defenses in subcutaneous mycoses. Clin Dermatol 2012;30:382-388.

  9. Rosas-Taraco AG, Perez-Liñan AR, Bocanegra-Ibarias P, Perez-Rivera LI, Salinas-Carmona MC. Nocardia brasiliensis induces an immunosuppressive microenvironment that favors chronic infection in BALB/c mice. Infect Immun 2012;80:2493-2499.

  10. Salinas-Carmona MC, Rocha-Pizaña MR. Construction of a Nocardia brasiliensis fluorescent plasmid to study actinomycetoma pathogenicity. Plasmid 2011;65:25-31.

  11. Gonzalez-Suárez ML, Salinas-Carmona MC, Pérez-Rivera I. IgM but not IgG monoclonal anti-Nocardia brasiliensis antibodies confer protection against experimental actinomycetoma in BALB/c mice. FEMS Immunol Med Microbiol 2009;57:17-24.

  12. Licón-Trillo A, Castro-Corona MA, Salinas-Carmona M. Immunogenicity and biophysical properties of a Nocardia brasiliensis protease involved in pathogenesis of mycetoma. FEMS Immunology & Medical Microbiology 2003;37:37-44.

  13. Vera-Cabrera L, Johnson W, Welsh O, Resendiz-Uresti F, Salinas-Carmona M. Distribution of a Nocardia brasiliensis catalase gene fragment in members of the genera Nocardia, Gordona, and Rhodococcus. J Clin Microbiol 1999;37:1971-1976.

  14. Salinas-Carmona M, Torres-López E, Ramos A, Licon-Trillo A, González-Spencer D. Immune response to Nocardia brasiliensis antigens in an experimental model of actinomycetoma in BALB/c mice. Infect Immun 1999;67:2428-2432.

  15. Salinas-Carmona M, Castro-Corona M, Sepúlveda-Saavedra J, Pérez L. Monoclonal antibodies to P24 and P61 immunodominant antigens from Nocardia brasiliensis. Clin Diagn Lab Immunol 1997;4:133-137.

  16. Salinas-Carmona M, Torres-López E. Role of passive humoral immunity in experimental mycetoma by Nocardia brasiliensis. Ann N Y Acad Sci 1996;25:263-265.

  17. Salinas-Carmona M, Welsh O, Casillas S. Enzyme-linked immunosorbent assay for serological diagnosis of Nocardia brasiliensis and clinical correlation with mycetoma infections. J Clin Microbiol 1993;31:2901-2906.

  18. Vera-Cabrera L, Salinas-Carmona M, Welsh O, Rodríguez M. Isolation and purification of two immunodominant antigens from Nocardia brasiliensis. J Clin Microbiol 992;30:1183-1188.

  19. Salinas-Carmona MC, Vera L, Welsh O, Rodríguez M. Antibody response to Nocardia brasiliensis antigens in man. Zentralbl Bakteriol 1992;276:390-397.

  20. Zijlstra EE, van de Sande WW, Welsh O, Mahgoub ES, et al. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis 2016;16:100-112.

  21. Welsh O, Vera-Cabrera L. Red face and fungi infection. Clin Dermatol 2014;32:734-738.

  22. Molina-Torres CA, Barba-Marines A, Valles-Guerra O, Ocampo-Candiani J, et al. Intracellular activity of tedizolid phosphate and ACH-702 versus mycobacterium tuberculosis infected macrophages. Ann Clin Microbiol Antimicrob 2014;13:13.

  23. Wendy WJ, van de Sande, Maghoub ES, Fahal AH, et al. The mycetoma knowledge gap: identification of research priorities. PLoS Negl Trop Dis 2014;8:2667.

  24. Vera-Cabrera L, Ortiz-Lopez R, Elizondo-Gonzalez R, Perez-Maya AA, Ocampo-Candiani J. Complete genome sequence of Nocardia brasiliensis HUJEG-1. J Bacteriol 2012;194:2761-2762.

  25. Almaguer-Chávez JA, Welsh O, Lozano-Garza HG, SaidFernández S, et al. Decrease of virulence for BALB/c mice produced by continuous subculturing of Nocardia brasiliensis. BMC Infect Dis 2011;11:290.

  26. Espinoza-Gonzalez N, Welsh O, Ocampo-Candiani J, SaidFernandez S, et al. Evaluation of the combined therapy of DA-7218, a new oxazolidinone, and trimethoprim/ sulfamethoxazole in the treatment of experimental actinomycetoma by Nocardia brasiliensis. Current Drug Delivery 2010;7:225-229.

  27. Vera-Cabrera L, Campos-Rivera MP, Escalante-Fuentes WG, Pucci MJ, et al. In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid. Antimicrob Agents Chemother 2010;54:2191-2193.

  28. Vera-Cabrera L, Espinoza-Gonzalez NA, Welsh O, OcampoCandiani J, Castro-Garza J. Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages. J Antimicrob Chemother 2009;64:1013-1017.

  29. Chacon-Moreno BE, Welsh O, Cavazos-Rocha N, SalazarCavazos MD, et al. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensisin vitro and in an experimental model of actinomycetoma in BALB/c Mice. Antimicrob Agents Chemother 2008;53:295-297.

  30. Vera-Cabrera L, Daw-Garza A, Said-Fernández S, LozanoGarza HG, et al. Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis. PLoS Negl Trop Dis 2008;2:289.

  31. Daw-Garza A, Welsh O, Said-Fernandez S, Lozano-Garza HG, et al. In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis. Antimicrob Agents Chemother 2008;52:1549-1550.

  32. Espinoza-González NA, Welsh O, Torres NW, Cavazos-Rocha N, et al. Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis. Molecules 2008;13:31-40.

  33. Cavazos-Rocha N, Vera-Cabrera L, Welsh-Lozano O, Waksman-De-Torres N, Salazar-Cavazos MD. Simultaneous determination and validation of antimicrobials in plasma and tissue of actinomycetoma by high-performance liquid chromatography with diode array and fluorescence detection. J Pharm Biomed Anal 2007;43:1775-1781.

  34. Vera-Cabrera L, Brown-Elliott BA, Wallace RJ, OcampoCandiani J, et al. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria. Antimicrob Agents Chemother 2006;50:4027-4029.

  35. Vera-Cabrera L, Gonzalez E, Rendon A, Ocampo-Candiani J, et al. In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis. Antimicrob Agents and Chemotherapy 2006;50:3170-3172.

  36. Vera-Cabrera L, Ochoa-Felix EY, Gonzalez G, Tijerina R, et al. In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae. Antimicrob Agents Chemother 2004;48:1037-1039.

  37. Gomez-Flores A, Welsh O, Said-Fernandez S, Lozano-Garza G, et al. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother 2004;48:832-837.

  38. Vera-Cabrera L, Gonzalez E, Choi SH, Welsh O. In vitro activities of new antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother 2004;48:602-604.

  39. Vera-Cabrera L, Gomez-Flores A, Escalante-Fuentes WG, Welsh O. In vitro activity of PNU-100766 (Linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob Agents Chemotherapy 2001;45:3629-3630.

  40. Welsh O, Gómez M, Mancias C, Ibarra-Leal S, Millikan LE. A new therapeutic approach to type II leprosy reaction. Int J Dermatol 1999;38:931-933.

  41. Gonzalez-Carrillo C, Millan-Sauceda C, Lozano-Garza HG, Ortiz-Lopez R, et al. Genomic changes associated with the loss of Nocardia brasiliensis virulence in mice after 200 in vitro passages. Infect Immun 2016;84:2595-2606.

  42. González-Martínez NA, Lozano-Garza HG, Castro-Garza J, Osio-Cortez AD, et al. In vivo activity of the benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis. PLoS Negl Trop Dis 2015;9:4022.

  43. Vera-Cabrera L, Escalante-Fuentes W, Ocampo-Garza SS, Ocampo-Candiani J, et al. Mycobacterium lepromatosis infections in Nuevo León, Mexico. J Clin Microbiol 2015;53:1945-1946.

  44. Vera-Cabrera L, Ortiz-López R, Elizondo-González R, Campos-Rivera MP, et al. Draft genome sequence of Actinomadura madurae LIID-AJ290, isolated from a human mycetoma case. Genome Announc 2014;2:201-214.



>Revistas >Dermatología Revista Mexicana >Año2016, No. 6
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019